Science Explorer Interactive view Map
Company · San Diego · United States

Vividion Therapeutics (United States)

vividion.comROR OpenAlex
Research works
26
▲ 1402% vs 2013–17
Citations
694
26.4 per fractional work
Top-10% rate
37.2%
record average 16.5%
Open access
62%
world 28%

Not ranked overall: Vividion Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.54× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 2.14× its world share, 0 worksImmunology and Micro…Neuroscience: 0.38× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.27× its world share, 0 worksPharmacology, Toxico…Chemistry: 10.78× its world share, 2 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringEnvironmental Science: 1.22× its world share, 1 worksEnvironmental ScienceMedicine: 1.19× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 0.13× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.3×. Every wedge is a field page.

Which keywords describe research at Vividion Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Transcriptional Regulation, BET Bromodomains, PROTACs, Medicinal Chemistry, Monoclonal Antibodies, Therapeutic Antibodies, Drug Discovery and TGF-ß.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Transcriptional Regulation4▲ 57×5 topics
  2. BET Bromodomains3▲ 535×1 topic
  3. PROTACs3▲ 535×1 topic
  4. Medicinal Chemistry2▲ 18×6 topics
  5. Cancer2▲ 4.6×11 topics
  6. Monoclonal Antibodies2▲ 46×3 topics
  7. Drug Discovery2▲ 15×4 topics
  8. Therapeutic Antibodies2▲ 49×2 topics
  9. TGF-ß2▲ 33×2 topics
  10. Antibody Engineering1▲ 54×1 topic
  11. CD4+CD25+1▲ 74×1 topic
  12. Fc Receptors1▲ 54×1 topic
  13. Foxp31▲ 74×1 topic
  14. Glycosylation1▲ 25×2 topics
  15. Oxidative Stress1▲ 2.6×8 topics
  16. Cancer Therapy1▲ 7.2×5 topics
  17. Therapeutic Targets1▲ 20×3 topics
  18. NK Cell Recognition1▲ 42×1 topic
  19. Natural Killer Cells1▲ 42×1 topic
  20. Catalysis1▲ 4.8×2 topics
  21. Chronic Lymphocytic Leukemia1▲ 78×1 topic
  22. Click Chemistry1▲ 49×1 topic
  23. Copper-Catalyzed Cycloaddition1▲ 119×1 topic
  24. Genomic Aberrations1▲ 78×1 topic
  25. Organic Synthesis1▲ 18×4 topics

Which research topics does Vividion Therapeutics (United States) publish most on?

By volume in 2022–2025: Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research, Chemistry and Chemical Engineering and History and advancements in chemistry.

Protein Degradation and …1Protein Degradation and Inhibitors: 1 fractional worksChronic Lymphocytic Leukemia Research: 1 fractional worksChemistry and Chemical Engineering: 1 fractional worksHistory and advancements in chemistry: 1 fractional worksEpigenetics and DNA Methylation: 0 fractional worksHistone Deacetylase Inhi…0Histone Deacetylase Inhibitors Research: 0 fractional worksRNA modifications and cancer: 0 fractional worksSignaling Pathways in Disease: 0 fractional worksPolyamine Metabolism and Applications: 0 fractional worksCancer-related gene regulation: 0 fractional works
Molecular BiologyGeneticsEnvironmental ChemistryPhysical and Theoretical Chemistry

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 1 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 1 works
  3. 3 Chemistry and Chemical Engineering Environmental Chemistry 1 works
  4. 4 History and advancements in chemistry Physical and Theoretical Chemistry 1 works
  5. 5 Epigenetics and DNA Methylation Molecular Biology 0 works
  6. 6 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
  7. 7 RNA modifications and cancer Molecular Biology 0 works
  8. 8 Signaling Pathways in Disease Molecular Biology 0 works
  9. 9 Polyamine Metabolism and Applications Molecular Biology 0 works
  10. 10 Cancer-related gene regulation Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.0%not open38.0%

World: 28% of research is openly available.

with international co-authors33.8%domestic only66.2%

World: 19% is written across borders.

How has Vividion Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 1402% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.